← FDA Drug Approvals (Drugs@FDA)

DOFETILIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GRANULES · Approved 2021-10-14

Drug application

FDA Application #

ANDA212750

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOFETILIDE

Generic name

DOFETILIDE 0.125MG

Active ingredients

DOFETILIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

GRANULES

Manufacturer

Granules Pharmaceuticals Inc.

First approval

2021-10-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown